# Home Monitoring to Predict Exacerbation in Cystic Fibrosis

> **NCT02416375** · — · COMPLETED · sponsor: **Papworth Hospital NHS Foundation Trust** · enrollment: 147 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02416375
- **Lead sponsor:** Papworth Hospital NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2018-01
- **Final completion:** 2019-01
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2021-03-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02416375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02416375, "Home Monitoring to Predict Exacerbation in Cystic Fibrosis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02416375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*